⌘K

Login Start Free

Home/Filings/4/0000950170-25-083885

4//SEC Filing

Honore Tage 4

Accession 0000950170-25-083885

CIK 0001347178other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 5:34 PM ET

Size

4.7 KB

Accession

0000950170-25-083885

Insider Transaction Report

Form 4

Period: 2025-06-05

Vanda Pharmaceuticals Inc.VNDA

Director

Transactions

Award
Common Stock
2025-06-05+59,225→ 123,469 total

Footnotes (1)

[F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 5, 2026, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1

filerCIK 0001967946

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 5:34 PM ET
Size: 4.7 KB

View on SEC.gov